Jaspreet Tiwana
Internal Medicine · Sacramento, CANPI 1871725895
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $560 and has fallen 73.6% since, to $148 in 2024.
Across 124 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$238
- Merck$223
- Novo Nordisk$214
- AbbVie$190
- Pfizer$179
- AstraZeneca$151
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,275100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $238 |
| Merck | 12 | $223 |
| Novo Nordisk | 16 | $214 |
| AbbVie | 8 | $190 |
| Pfizer | 11 | $179 |
| AstraZeneca | 10 | $151 |
| Boehringer Ingelheim | 7 | $149 |
| Abbott | 1 | $106 |
| Lilly USA, LLC | 5 | $93 |
| Biohaven Pharmaceuticals, Inc. | 4 | $87 |
| Novartis | 5 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $68 |
| Ironwood Pharmaceuticals, Inc | 4 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Optinose US, Inc. | 2 | $45 |
| Amgen | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $29 |
| Exact Sciences | 1 | $29 |
| Hologic Sales And Service, LLC | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Bausch Health US, LLC | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Qiagen, LLC | 1 | $21 |
| Seqirus USA Inc | 1 | $20 |
| Silk Road Medical, Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| VBI Vaccine (delaware) Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,275 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 16 | $20,358 |
| EliquisApixaban | 21 | $14,494 |
| Atorvastatin Calcium | 93 | $1,030 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $997 |
| Levothyroxine Sodium | 75 | $893 |
| Metformin Hcl | 71 | $810 |
| Losartan Potassium | 85 | $802 |
| Amlodipine Besylate | 94 | $703 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $566 |
| Alendronate Sodium | 45 | $519 |
| Fluticasone Propionate | 20 | $463 |
| Omeprazole | 24 | $402 |
| Hydralazine Hcl | 19 | $363 |
| Metoprolol Succinate | 28 | $347 |
| Tamsulosin Hcl | 22 | $303 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $149 | $20,35816 claims |
| PfizerEliquis | $179 | $14,49421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Sacramento
- Christian SandrockSacramento$2.1M
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.